scholarly journals Ampulla of Vater Villous Adenoma

2020 ◽  
Author(s):  
1997 ◽  
Vol 84 (4) ◽  
pp. 581-581
Author(s):  
F. Abbasakoor ◽  
J. Mck. Manson ◽  
N. D. Carr

1990 ◽  
Vol 4 (6) ◽  
pp. 235-236
Author(s):  
SR Choudhury ◽  
AK Malik ◽  
Y Chawla ◽  
JD Wig

Biliary obstruction due to a benign villous adenoma of the ampulla of Vater treated by transduodenal local excision and sphincteroplasty is reported. Local surgical resection enabled a submucosal resection of the adenoma.


1979 ◽  
Vol 25 (4) ◽  
pp. 155-156 ◽  
Author(s):  
Michael Taxier ◽  
Michael V. Sivak ◽  
Avram Cooperman

HPB Surgery ◽  
2000 ◽  
Vol 11 (5) ◽  
pp. 325-331 ◽  
Author(s):  
C. Hoyuela ◽  
E. Cugat ◽  
E. Veloso ◽  
C. Marco

Introduction: Duodenal villous adenoma arising from the ampulla of Vater has a high risk of malignant development. Excluding associated malignant disease prior to resection of an adenoma of the ampulla is not always possible. Therefore, the surgical procedure of choice to treat this rare tumour is still controversial.Objective: To evaluate retrospectively results of treatment of villous adenoma arising from ampulla of Vater with dysplasia or associated carcinoma limited to the ampulla.Patients and Methods: From 1985 to 1996, eight patients have been diagnosed with ampullary villous adenoma suitable for resection. We have reviewed treatment, morbidity, mortality, follow-up and final outcome.Results: Pancreatoduodenectomy (PD) was performed in 4 patients. Transduodenal ampullectomy and endoscopic resection was performed in 2 patients each. There was no perioperative mortality. None of the patients had biliary, pancreatic or intestinal leakage but two patients who underwent PD had minor postoperative complications. The mean follow-up was 44 (range: 6–132) months. Villous adenoma was associated with adenocarcinoma in 50% of the cases (4/8 patients). During the followup both patients who underwent transduodenal ampullectomy developed recurrent disease. All patients initially treated by PD are alive without evidence of recurrent disease.Conclusions: Treatment of villous adenoma of the ampulla must be individualized within certain limits. In our series, PD achieve good results and it appears to be the procedure of choice in order to treat villous adenomas with proved presence of carcinoma, carcinoma in situ or severe dysplasia. Endoscopic or local resection may be appropriate for small benign tumours in high risk patients.


1997 ◽  
Vol 84 (7) ◽  
pp. 948-951 ◽  
Author(s):  
D. L. Cahen ◽  
P. Fockens ◽  
L. Th. de Wit ◽  
G. J. A. Offerhaus ◽  
H. Obertop ◽  
...  

1982 ◽  
Vol 28 (2) ◽  
pp. 114
Author(s):  
Mark A. Nicklanovich

1978 ◽  
Vol 75 (1) ◽  
pp. 107-109 ◽  
Author(s):  
Steven Sobol ◽  
Avram M. Cooperman

1985 ◽  
Vol 61 (722) ◽  
pp. 1077-1078 ◽  
Author(s):  
A. K. Malik ◽  
M. K. Baruah ◽  
N. Pravin ◽  
R. N. Kataria

HPB Surgery ◽  
1996 ◽  
Vol 10 (2) ◽  
pp. 105-109 ◽  
Author(s):  
Gaetano Catania ◽  
Francesco Cardi ◽  
Marcello Migliore ◽  
Gaetano Romeo

We report a case of villous adenocarcinoma of duodenum arising from the ampulla of Vater with a review of the literature. Although preoperative endoscopic biopsies were performed, no malignancy was identified. Because of the pathological uncertainty we decided to perform a pylorus-preserving pancreatoduodenectomy. Microscopic examination demonstrated glandular dysplasia with aspects of villous adenoma and well differentiated adenocarcinoma. We conclude that both in malignant cases and in cases with uncertain diagnosis a pylorus-preserving pancreatoduodenectomy is the best surgical treatment because it results in better 5 year survival.


Sign in / Sign up

Export Citation Format

Share Document